<DOC>
	<DOCNO>NCT00161824</DOCNO>
	<brief_summary>The purpose study assess safety vaccination schedule consist two vaccination ( 21-35 day apart ) tick-borne encephalitis ( TBE ) vaccine FSME-IMMUN NEW ( 5 consecutive lot ) comparison another licensed TBE vaccine ( EncepurÂ® adult , polygeline ) ( 2 lot ) healthy volunteer age 16 65 year .</brief_summary>
	<brief_title>Safety Study Volunteers From 16 65 Years Age : FSME IMMUN NEW vs. ENCEPUR</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Tick-Borne</mesh_term>
	<criteria>Male female volunteer eligible participation study : Were 16 year ( 16th birthday ) 65 year ( last day 65th birthday ) old Were clinically healthy Had negative pregnancy test first medical examination , female capable bearing child Agreed employ adequate birth control measure duration study , female capable bearing child Provided write informed consent For volunteer 18 year age write informed consent parent / guardian available Agreed keep volunteer diary History previous TBE vaccination History TBE infection show evidence latent TBE infection ( demonstrated screening ELISA &gt; 126 VIEU/ml ) History allergic reaction , particular one component vaccine Previously receive volume substitution product contain polygeline ( stabilizer ENCEPUR ) Received antipyretic within 4 hour prior first TBE vaccination Suffer disease effectively treat stabilized Suffering disease ( e.g . autoimmune disease ) undergo form treatment could expect influence immunological function Suffering chronic , degenerative and/or inflammatory disease central nervous system Using immunosuppressive drug ( e.g . local systemic corticosteroid , chemotherapeutics ) Had know suspect problem drug alcohol abuse ( &gt; 4 liter wine / week equivalent level alcoholic beverage ) Had donate blood plasma within one month study start Had receive bank blood immunoglobulin within one month study entry Known HIV positive ( special HIV test require purpose study ) Suffering febrile illness study entry History vaccination yellow fever / Japanese B encephalitis Participating simultaneously another clinical trial If female : pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>